Psmb6 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [1]
PSMB6 (Proteasome Subunit Beta Type 6) encodes the β6 subunit of the 20S proteasome, which provides the trypsin-like proteolytic activity essential for protein degradation. This catalytic subunit cleaves after basic residues (Arg, Lys), complementing the chymotrypsin-like (PSMB5) and caspase-like (PSMB1) activities to create the complete proteolytic repertoire of the proteasome. PSMB6 is crucial for maintaining protein homeostasis) in neurons, and its dysfunction contributes to protein aggregate accumulation in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. [2]
| Property | Value | [3]
|----------|-------| [4]
| Protein Name | Proteasome Subunit Beta Type 6 |
| Gene | PSMB6 |
| UniProt ID | P60900 |
| PDB ID | 5MX3 |
| Molecular Weight | 25.4 kDa |
| Subcellular Localization | Cytoplasm, Nucleus |
| Protein Family | Proteasome beta subunit family |
| Catalytic Activity | Trypsin-like |
The PSMB6 protein is a 241-amino acid subunit containing the N-terminal threonine catalytic residue. It adopts the characteristic α/β fold of proteasome β-subunits.
PSMB6 incorporates into the inner β-ring during proteasome biogenesis:
The study of Psmb6 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Bedford L, et al. Proteasome in neurons. Prog Mol Biol Transl Sci. 2011;98:415-432. 2011. ↩︎
Tai HC, Schuman EM. Ubiquitin and proteasome in neuronal diseases. Nat Rev Neurosci. 2008;9(11):826-838. 2008. ↩︎
Liu Y, et al. Proteasome inhibition and dopaminergic cell death. J Neurochem. 2020;154(5):506-523. 2020. ↩︎
Dantuma NP, Bott LC. UPS in neurodegenerative diseases. J Alzheimers Dis. 2010;20(1):S131-S146. 2010. ↩︎